Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Central Nervous System Disease
|
June 29, 2026
Correlation Is Not Prediction: Reassessing Predictive MRI Evidence in Guidelines for Persons With Relapsing-Remitting Multiple Sclerosis
Dulat Minas, Stefan Buchka, Joachim Havla, et al.
Plos One
|
December 26, 2025
Individual-level surrogacy of MRI lesions for disease severity in RRMS: Methods to quantify predictive power and their application to longitudinal data from recent trials
Stefan Buchka, Joachim Havla, Begüm Irmak Ön, et al.
Genome Biology
|
May 12, 2021
On the optimistic performance evaluation of newly introduced bioinformatic methods
Stefan Buchka, Alexander Hapfelmeier, Paul P Gardner, et al.
International Journal of Molecular Sciences
|
August 26, 2023
Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis
Jonathan A Gernert, Luise Böhm, Michaela Starck, et al.
Journal of Neurology
|
October 5, 2021
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
Katharina Eisenhut, Stefan Buchka, Peter Eichhorn, et al.
Studies in Health Technology and Informatics
|
May 23, 2026
Data Quality in the ProVal-MS Study: Challenges and Lessons Learned
Peter Pallaoro, Sandra Bilger, Martin Boeker, et al.
BMC Medicine
|
May 21, 2026
Cost-effectiveness of prehabilitation for elderly (pre-)frail patients prior to elective surgery compared to standard care - an economic evaluation from a societal perspective
Tanja Rombey, Helene Eckhardt, Wilm Quentin, et al.
Plos Genetics
|
December 28, 2020
Lotus japonicus karrikin receptors display divergent ligand-binding specificities and organ-dependent redundancy
Samy Carbonnel, Salar Torabi, Maximilian Griesmann, et al.
Neurological Research and Practice
|
March 6, 2024
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study
Antonios Bayas, Ulrich Mansmann, Begum Irmak Ön, et al.
Therapeutic Advances in Neurological Disorders
|
November 24, 2025
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study
Stefan Buchka, Alexander Hapfelmeier, Jan S Kirschke, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Central Nervous System Disease
|
June 29, 2026
Correlation Is Not Prediction: Reassessing Predictive MRI Evidence in Guidelines for Persons With Relapsing-Remitting Multiple Sclerosis
Dulat Minas, Stefan Buchka, Joachim Havla, et al.
Plos One
|
December 26, 2025
Individual-level surrogacy of MRI lesions for disease severity in RRMS: Methods to quantify predictive power and their application to longitudinal data from recent trials
Stefan Buchka, Joachim Havla, Begüm Irmak Ön, et al.
Genome Biology
|
May 12, 2021
On the optimistic performance evaluation of newly introduced bioinformatic methods
Stefan Buchka, Alexander Hapfelmeier, Paul P Gardner, et al.
International Journal of Molecular Sciences
|
August 26, 2023
Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis
Jonathan A Gernert, Luise Böhm, Michaela Starck, et al.
Journal of Neurology
|
October 5, 2021
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
Katharina Eisenhut, Stefan Buchka, Peter Eichhorn, et al.
Studies in Health Technology and Informatics
|
May 23, 2026
Data Quality in the ProVal-MS Study: Challenges and Lessons Learned
Peter Pallaoro, Sandra Bilger, Martin Boeker, et al.
BMC Medicine
|
May 21, 2026
Cost-effectiveness of prehabilitation for elderly (pre-)frail patients prior to elective surgery compared to standard care - an economic evaluation from a societal perspective
Tanja Rombey, Helene Eckhardt, Wilm Quentin, et al.
Plos Genetics
|
December 28, 2020
Lotus japonicus karrikin receptors display divergent ligand-binding specificities and organ-dependent redundancy
Samy Carbonnel, Salar Torabi, Maximilian Griesmann, et al.
Neurological Research and Practice
|
March 6, 2024
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study
Antonios Bayas, Ulrich Mansmann, Begum Irmak Ön, et al.
Therapeutic Advances in Neurological Disorders
|
November 24, 2025
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study
Stefan Buchka, Alexander Hapfelmeier, Jan S Kirschke, et al.
Page
of 1